YYZ-13139-58348
4 vaccinations
4 coded responses
28 check-ins
4 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 61-65
- ZIP prefix
- 982 / WA
- Registered
- 2021-03-24
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-03
Dose 1 — Moderna
-
2021-03-24
Registered in v-safe
-
2021-03-24
Survey response — day 21, dose 1MedDRA: Conjunctivitis, Office visit, Tinnitus — Feeling: Good · Get care from a doctor or other healthcare professionalFree text: Symptoms: Conjunctivitis (started before shot, but it endures)Tinnitus (my theories include possibly due to antibiotic drops for eye (prescribed before visit to Dr.. Now the ophthalmologist thinks viral). Or pepcid ac? Never have had pinkeye for 3 weeks-plus! · Healthcare visit (other): Doctor Office for eyesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-24
Report sent to call center — day 21, dose 1Get care from a doctor or other healthcare professionalno matching call case
-
2021-03-31
Dose 2 — Moderna
-
2021-04-07
Survey response — day 7, dose 2MedDRA: Adverse reaction, Unevaluable event — Feeling: Good · Site: RednessFree text: Day after 2nd shot yes. None todayMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-15
- 2021-04-21
- 2021-04-29
- 2021-05-13
- 2021-07-01
- 2021-09-29
-
2021-10-27
Dose 3 — Moderna
-
2021-10-28
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-10-29
Survey response — days 1–6 daily, dose 3MedDRA: Therapeutic response unexpected — Feeling: Good · Rash, not including the immediate area around the injection siteFree text: I usually get viral exanthema after a cold. Red first then itching after has faded and im over illness. Shorter timeline with vaxMedDRA releases: 2024-11 · check-in free text available
-
2021-10-30
Survey response — days 1–6 daily, dose 3MedDRA: Nasopharyngitis, Pain, Pre-existing disease — Feeling: Good · Rash, not including the immediate area around the injection siteFree text: As with yesterday, have viral exanthem as i normally do when aches/pains of a cold subside.MedDRA releases: 2024-11 · check-in free text available
- 2021-10-31
- 2021-11-01
- 2021-11-02
- 2021-11-03
- 2021-11-10
- 2021-11-20
- 2021-11-24
- 2021-12-04
- 2021-12-10
- 2022-01-26
-
2022-04-10
Dose 4 — Pfizer-BioNTech
- 2022-04-14
- 2022-04-16
- 2022-04-18
- 2022-04-26
- 2022-05-04
- 2022-05-08
- 2022-05-15
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-03 | Moderna | |
| 2 | 2021-03-31 | Moderna | |
| 3 | 2021-10-27 | Moderna | No |
| 4 | 2022-04-10 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|
1 report(s) with no call case — see the timeline.
Free text
Release 6 — day 21, dose 1
Symptoms: Conjunctivitis (started before shot, but it endures)Tinnitus (my theories include possibly due to antibiotic drops for eye (prescribed before visit to Dr.. Now the ophthalmologist thinks viral). Or pepcid ac? Never have had pinkeye for 3 weeks-plus! cut off by CDC
Healthcare visit (other): Doctor Office for eyes
Release 7 — day 7, dose 2
Systemic reaction (other): Day after 2nd shot yes. None today
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): I usually get viral exanthema after a cold. Red first then itching after has faded and im over illness. Shorter timeline with vax
Systemic reaction (other): As with yesterday, have viral exanthem as i normally do when aches/pains of a cold subside.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | ✓ | ✓ | ✓ |
| SD | Conjunctivitis | ✓ | ✓ | ✓ |
| SD | Tinnitus | ✓ | ✓ | ✓ |
| SRO | Adverse reaction | · | · | ✓ |
| SRO | Nasopharyngitis | · | · | ✓ |
| SRO | Pain | · | · | ✓ |
| SRO | Pre-existing disease | · | · | ✓ |
| SRO | Therapeutic response unexpected | · | · | ✓ |
| SRO | Unevaluable event | ✓ | ✓ | ○ |
✓ active code · ○ coded but marked inactive · blank = not in that release